Relação entre ototoxicidade e uso de Hidroxicloroquina em pacientes com lúpus eritematoso sistêmico

Autores

DOI:

https://doi.org/10.34024/rnc.2022.v30.13494

Palavras-chave:

Hidroxicloroquina, Perda Auditiva, Lúpus Eritematoso Sistêmico, Audição

Resumo

Introdução. Há décadas a hidroxicloroquina (HCQ) vem sendo utilizada no tratamento de pacientes com Lupus Eritematoso Sistêmico (LES) e um número crescente de estudos tem destacado o potencial efeito protetor desta medicação por meio de múltiplos mecanismos de ação, oferecendo aos indivíduos com LES maior sobrevida. Objetivo. Apresentar evidências científicas com base em revisão sistemática da literatura (PRISMA) sobre os possíveis efeitos ototóxicos da hidroxicloroquina em pacientes com LES. Método. Para a seleção dos estudos foi utilizada a combinação baseada no Medical Subject Heading Terms (MeSH). Foram utilizadas as bases de dados Medline (Pubmed), LILACS, SciELO, SCOPUS, WEB OF SCIENCE e BIREME. As buscas por artigos científicos foram conduzidas sem restrição de idioma, período e localização. Resultados. Foram encontrados 315 artigos com potencial de inclusão, sendo que apenas um artigo respondeu aos critérios de inclusão e à pergunta norteadora que consistiu em verificar se o uso da hidroxicloroquina causa efeitos no sistema auditivo de pacientes com Lúpus. Esse estudo obteve pontuação onze (alta qualidade) no protocolo modificado de Pithon (2015), para avaliação da qualidade dos mesmos. Conclusão. Ainda há divergências sobre a relação causal entre perda auditiva e o uso da HCQ no tratamento do LES. Alterações auditivas são frequentemente encontradas nestes pacientes, porém ainda há dúvidas quanto à verdadeira etiologia destas alterações.

Downloads

Não há dados estatísticos.

Métricas

Carregando Métricas ...

Referências

Iozza I, Cianci S, Di Natale A, Garofalo G, Giacobbe AM, Giorgio E, et al. Update on systemic lupus erythematosus pregnancy. J Prenat Med 2010;4:67-73. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279186/

Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR, et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005;52:1138-47. https://doi.org/10.1002/art.20999

Finckh A, Cooper GS, Chibnik LB, Costenbader KH, Watts J, Pankey H, et al. Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis Rheum 2006;54:3648-54. https://doi.org/10.1002/art.22210

Harley IT, Kaufman KM, Langefeld CD, Harley JB, Kelly JA. Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet 2009;10:285-90. https://doi.org/10.1038/nrg2571

Tan IJ, Peeva E, Zandman-Goddard G. Hormonal modulation of the immune system-A spotlight on the role of progestogens. Autoimmun Rev 2015;14:536-42. https://doi.org/10.1016/j.autrev.2015.02.004

Heinlen LD, McClain MT, Merrill J, Akbarali YW, Edgerton CC, Harley JB, et al. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum 2007;56:2344-51. https://doi.org/10.1002/art.22665

Yu C, Gershwin ME, Chang C. Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun 2014;48/49:10-3. https://doi.org/10.1016/j.jaut.2014.01.004

Olsen NJ, Schleich MA, Karp DR. Multifaceted effects of hydroxychloroquine in human disease. Semin Arthritis Rheum 2013;43:264-72. https://doi.org/10.1016/j.semarthrit.2013.01.001

Floris A, Piga M, Mangoni A, Bortoluzzi A, Erre G, Cauli A. Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus. Mediators Inflamm 2018;2018:3424136. https://doi.org/10.1155/2018/3424136

Dauman R, Dulon D. Ototoxicidad medicamentosa. Encyclop Méd Chirurg 1995;20:184-B-0. https://doi.org/10.1016/S1632-3475(00)71950-3

Bernard P. Alteration of auditory evoked potentials during the course of chloroquine treatment. Acta Otolaryngol 1985;99:387-92. https://doi.org/10.3109/00016488509108928

Hadi U, Nuwayhtd N, Hasbini AS. Chloroquine ototoxicity: an idiosyncratic phenomenon. Otolaryngol Head Neck Surg 1996;114:491-3. https://doi.org/10.1016/s0194-5998(96)70226-7

Figueiredo MC, Atherino CCCT, Monteiro CV, Levy RA. Antimalarials and Ototoxicity. Rev Bras Reumatol 2004;44:212-4. https://www.scielo.br/j/rbr/a/WmRt5ptTHk8CbcFBVpt3x4d/?format=pdf&lang=pt

Johansen PB, Gran JT. Ototoxicity due to hydroxychloroquine: report of two cases. Clin Exp Rheumatol 1998;16:472-4. https://pubmed.ncbi.nlm.nih.gov/9706431/

Coutinho M, Duarte I. Hydroxychloroquine ototoxicity in a child with idiopathic pulmonary haemosiderosis. Int J Pediatr Otorhinolaryngol 2002;62:53-7. https://doi.org/10.1016/s0165-5876(01)00592-4

Bortoli R, Santiago M. Chloroquine ototoxicity. Clin Rheumatol 2007;26:1809-10. https://doi.org/10.1007/s10067-007-0662-6

Fernandes MRN, Soares DBR, Thien C, Carneiro S. Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus. An Bras Dermatol 2018;93:474-5. https://doi.org/10.1590/abd1806-4841.20187615

Seckin U, Ozoran K, Ikinciogullari A, Borman P, Bostan EE. Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. Rheumatol Int 2000;19:203-4.

https://doi.org/10.1007/s002960000054

Khalili H, Dastan F, Manshadi S. A case report of hearing loss post use of hydroxychloroquine in a HIV-infected patient. Daru 2014;22:20. https://doi.org/10.1186/2008-2231-22-20

Lim SC, Tang SP. Hydroxychloroquine-induced ototoxicity in a child with systemic lupus erythematosus. Int J Rheum Dis 2011;14:e1-2. https://doi.org/10.1111/j.1756-185X.2010.01582.x

Cecatto SB, Garcia RID, Costa KS, Anti SMA, Longone E, Rapoport PB. Perda auditiva sensorioneural no lúpus eritematoso sistêmico: relato de três casos. Rev Bras Otorrinolaringol 2004;70:398-403. https://doi.org/10.1590/S0034-72992004000300017

Roverano S, Cassano G, Paira S, Chiavarini J, Graf C, Rico L, et al. Asymptomatic Sensorineural Hearing Loss in Patients With Systemic Lupus Erythematosus. J Clin Rheumatol 2006;12:217-20. https://doi.org/10.1097/01.rhu.0000242777.71604.69

Khalidi N, Rebello R, Robertson D. Sensorineural hearing loss in systemic lupus erythematosus: Case report and literature review. J Laryngol Otol 2008;122:1371-6.

https://doi.org/10.1017/S0022215108001783

Abbasi M, Yazdi Z, Kazemifar AM, Bakhsh ZZ. Hearing loss in patients with systemic lupus erythematosus. Glob J Health Sci 2013;5:102-6. https://doi.org/10.5539/gjhs.v5n5p102

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A (deceased), Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Ver 2015;4:1. https://doi.org/10.1186/2046-4053-4-1

Pithon MM, Santanna LIDA, Baião FCS, Santos RL, Coqueiro RS, Maia LC. Assessment of the effectiveness of mouthwashes in reducing cariogenic biofilm in orthodontic patients: A systematic review. J Dent 2015;43:297-308. https://doi.org/10.1016/j.jdent.2014.12.010

Maciaszczyk K, Durko T, Waszczkowska E, Erkiert-Polguj A, Pajor A. Auditory function in patients with systemic lupus erythematosus. Auris Nasus Larynx 2011;38:26-32. https://doi.org/10.1016/j.anl.2010.04.008

Lin C, Lin SW, Weng SF, Lin YS. Risk of sudden sensorineural hearing loss in patients with systemic lupus erythematosus: a population-based cohort study. Audiol Neuro Otol 2013;18:95-100. https://doi.org/10.1159/000345512

Rezende MSM, Iório MCM. Potenciais evocados auditivos: estudo com indivíduos portadores de lúpus eritematoso sistêmico. Rev Bras Otorrinolaringol 2008;74:429-39. https://doi.org/10.1590/S0034-72992008000300019

Akemi E. Audiological aspects of systemic lúpus Erythematosus carriers users of antimalaric medication. Rev Méd Paraná 2019;77:9-14. https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1010335

Sociedade Brasileira de Reumatologia. O Tratamento do Lúpus Eritematoso Sistêmico (endereço na internet). Acessado em 28/abr/2020. Disponível em:

https://www.reumatologia.org.br/orientacoes-ao-paciente/o-tratamento-do-lupus-eritematoso-sistemico/

Karatas E, Onat AM, Durucu C, Baglam T, Kanlikama M, Altunoren O, et al. Audiovestibular disturbance in patients with systemic lupus erythematosus. Otolaryngol Head Neck Surg 2007;136:82-6. https://doi.org/10.1016/j.otohns.2006.06.1255

Gad GI, Mohamed ST, Awwad KS, Mohamed RF. Study of audiovestibular dysfunction in children with systemic lupus erythematosus. Int J Pediatr Otorhinolaryngol 2013;77:1561-6. https://doi.org/10.1016/j.ijporl.2013.07.004

Kurita M, Chihara M, Itoh M, Asahina A, Yamamoto Ka, Yanaba K. Hearing loss caused by discoid lupus erythematosus of the ear canal successfully treated with hydroxychloroquine. J Dermatol 2019;46:e313-4. https://doi.org/10.1111/1346-8138.14875

Chatelet J, Auffret M, Combret S, Bondon-Guitton E, Lambert M, Gautier S. Surdité sous-hydroxychloroquine: premier cas de réintroduction positive et analyse de la base française de pharmacovigilance. Rev Méd Interne 2017;38:340-3. https://doi.org/10.1016/j.revmed.2016.07.008

Gomides APM, Rosário EJ, Borges HM, Gomides HHM, Pádua PM, Sampaio-Barros PD. Sensorineural dysacusis in patients with systemic lupus erythematosus. Lupus 2007;16:987-90. https://doi.org/10.1177/0961203307084160

Batuecas-Caletrio A, Pino-Montes J, Cordero-Civantos C, Calle-Cabanilas MI, Lopez-Escamez JA. Hearing and vestibular disorders in patients with systemic lupus erythematosus. Lupus 2013;22:437-42. https://doi.org/10.1177/0961203313477223

Kariya S, Kaya S, Hizli Ö, Hizli P, Nishizaki K, Paparella MM, et al. Cochlear Histopathologic Findings in Patients With Systemic Lupus Erythematosus: A Human Temporal Bone Study. Otol Neurotol 2016;37:593-7. https://doi.org/10.1097/MAO.0000000000001017

Lasso de la Vega M, Villarreal IM, López Moya J, García-Berrocal JR. Extended high frequency audiometry can diagnose sub-clinic involvement in a seemingly normal hearing systemic lupus erythematosus population. Acta Otolaryngol 2017;137:161-6. https://doi.org/10.1080/00016489.2016.1219049

Sperling NM, Tehrani K, Liebling A, Ginzler E. Aural symptoms and hearing loss in patients with lúpus. Otolaryngol Head Neck Surg 1998;118:762-5. https://doi.org/10.1016/S0194-5998(98)70265-7

Jiménez-Alonson J, Gutiérrez-Cabello F, Castillo JL, Sabio JM, Hidalgo-Tenorio C, León L, et al. Ear involvement in systemic lupus erythematosus patients: a comparative study. J Laryngol Otol 2002;116:746. https://doi.org/10.1258/0022215021910032

Downloads

Publicado

2022-08-10

Como Citar

Soares Aurélio Pattat, F. ., Faustino Gonçalves , L., Haas, P., & de Paiva, K. M. (2022). Relação entre ototoxicidade e uso de Hidroxicloroquina em pacientes com lúpus eritematoso sistêmico. Revista Neurociências, 30, 1–22. https://doi.org/10.34024/rnc.2022.v30.13494

Edição

Seção

Revisão Sistemática
Recebido: 2022-02-12
Aceito: 2022-06-09
Publicado: 2022-08-10

Artigos mais lidos pelo mesmo(s) autor(es)